Dearen Danny L. 4
4 · Axonics, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Axonics, Inc.AXNX
Dearen Danny L.
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2023-09-29+11,250→ 31,452 total - Exercise/Conversion
Performance-Based Restricted Stock Units
2023-09-29−11,250→ 0 totalFrom: 2024-01-31→ Common Stock (11,250 underlying) - Sale
Common Stock
2023-09-29$56.87/sh−7,675$436,490→ 23,777 total
Footnotes (3)
- [F1]Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein.
- [F2]This transaction was executed in multiple trades at prices ranging from $56.51 to $57.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023. The units represented here are pro-rated through the date of separation.